NY‐ESO‐1‐positive cases showed a trend towards a poorer outcome (Figure 3 B), but there was no difference after accounting for TN status (Figure 3 D).
← all excerpts
Expression of MAGE-A and NY-ESO-1 cancer/testis antigens is enriched in triple-negative invasive breast cancers.
2
—
—
The sentences
The CTAs (particularly NY‐ESO‐1) were also associated with expression of vimentin (a marker of mesenchymal differentiation), and were inversely associated with AR expression (Table 1 ), although these associations did not reach statistical significance within the TN group (not shown).